Detalles de la búsqueda
1.
Impact on visual acuity and psychological outcomes of ranibizumab and subsequent treatment for diabetic macular oedema in Japan (MERCURY).
Graefes Arch Clin Exp Ophthalmol
; 260(2): 477-487, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34477927
2.
Elevation of the vitreous body concentrations of oxidative stress-responsive apoptosis-inducing protein (ORAIP) in proliferative diabetic retinopathy.
Graefes Arch Clin Exp Ophthalmol
; 257(7): 1519-1525, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31062144
3.
Evaluation of vitreous levels of advanced glycation end products and angiogenic factors as biomarkers for severity of diabetic retinopathy.
Int Ophthalmol
; 38(2): 607-615, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28299499
4.
Relationships between vitreous levels of soluble receptor for advanced glycation end products (sRAGE) and renal function in patients with diabetic retinopathy.
Int Ophthalmol
; 37(6): 1247-1255, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27830398
5.
Æ©excessA1C index, the sum of yearly excess HbA1c values during the total period of diabetes, may have the potential to predict retinopathy by a linear regression setting regardless of duration in type 1 diabetes: a subgroup analysis of DCCT/EDIC data.
Diabetol Int
; 14(4): 440-444, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37781457
6.
Correction: Æ©excessA1C index, the sum of yearly excess HbA1c values during the total period of diabetes, may have the potential to predict retinopathy by a linear regression setting regardless of duration in type 1 diabetes: a subgroup analysis of DCCT/EDIC data.
Diabetol Int
; 14(4): 445, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37781460
7.
Comparison of the Effect of Bromfenac versus Betamethasone Ophthalmic Solutions in Patients with Diabetic Macular Edema.
Curr Eye Res
; 48(1): 80-85, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36331099
8.
Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trial.
Jpn J Ophthalmol
; 67(3): 264-279, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36897413
9.
Correction: Sugimoto et al. Trends in the Prevalence and Progression of Diabetic Retinopathy Associated with Hyperglycemic Disorders during Pregnancy in Japan. J. Clin. Med. 2022, 11, 165.
J Clin Med
; 11(10)2022 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35629076
10.
Treatment of diabetic macular edema in real-world clinical practice: The effect of aging.
J Diabetes Investig
; 13(8): 1339-1346, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35389565
11.
[Vitrectomy for proliferative diabetic retinopathy].
Nihon Rinsho
; 74 Suppl 2: 129-34, 2016 Apr.
Artículo
en Japonés
| MEDLINE | ID: mdl-27266075
12.
Is Chronic Kidney Disease Affecting the Postoperative Complications of Vitrectomy for Proliferative Diabetic Retinopathy?
J Clin Med
; 10(22)2021 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34830589
13.
Potential bias of preoperative intravitreal anti-VEGF injection for complications of proliferative diabetic retinopathy.
PLoS One
; 16(10): e0258415, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34624063
14.
Trends in the Prevalence and Progression of Diabetic Retinopathy Associated with Hyperglycemic Disorders during Pregnancy in Japan.
J Clin Med
; 11(1)2021 Dec 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-35011906
15.
Vitreous hemorrhage in diabetes patients with proliferative diabetic retinopathy undergoing hemodialysis.
J Diabetes Investig
; 11(3): 688-692, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-31618517
16.
Prognostic factors of revitrectomy for complications in eyes with proliferative diabetic retinopathy: a retrospective multicentre study.
Acta Ophthalmol
; 98(4): e434-e439, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31674137
17.
Real-world management of treatment-naïve diabetic macular oedema: 2-year visual outcome focusing on the starting year of intervention from STREAT-DMO study.
Br J Ophthalmol
; 104(12): 1755-1761, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32169861
18.
Real-world management of treatment-naïve diabetic macular oedema in Japan: two-year visual outcomes with and without anti-VEGF therapy in the STREAT-DME study.
Br J Ophthalmol
; 104(9): 1209-1215, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31784500
19.
Impact of variants in the VEGF gene on progression of proliferative diabetic retinopathy.
Graefes Arch Clin Exp Ophthalmol
; 247(1): 21-6, 2009 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-18709380
20.
Factors associated with non-proliferative diabetic retinopathy in patients with type 1 and type 2 diabetes: the Japan Diabetes Complication and its Prevention prospective study (JDCP study 4).
Diabetol Int
; 10(1): 3-11, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30800559